Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1.

Nakai Y, Isayama H, Ijichi H, Sasaki T, Kogure H, Yagioka H, Miyabayashi K, Mizuno S, Yamamoto K, Mouri D, Kawakubo K, Yamamoto N, Hirano K, Sasahira N, Tateishi K, Tada M, Koike K.

Cancer Sci. 2012 Aug;103(8):1489-92. doi: 10.1111/j.1349-7006.2012.02311.x. Epub 2012 Jun 15.

PMID:
22515232
[PubMed - indexed for MEDLINE]
2.

A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2.

Nakai Y, Isayama H, Ijichi H, Sasaki T, Takahara N, Ito Y, Matsubara S, Uchino R, Yagioka H, Arizumi T, Hamada T, Miyabayashi K, Mizuno S, Yamamoto K, Kogure H, Yamamoto N, Hirano K, Sasahira N, Tateishi K, Tada M, Koike K.

Invest New Drugs. 2013 Oct;31(5):1294-9. doi: 10.1007/s10637-013-9972-5. Epub 2013 May 21.

PMID:
23690239
[PubMed - indexed for MEDLINE]
3.

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.

Starling N, Watkins D, Cunningham D, Thomas J, Webb J, Brown G, Thomas K, Oates J, Chau I.

J Clin Oncol. 2009 Nov 20;27(33):5499-505. doi: 10.1200/JCO.2008.21.5384. Epub 2009 Oct 26.

PMID:
19858399
[PubMed - indexed for MEDLINE]
Free Article
4.

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.

Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Charnsangavej C, Abbruzzese JL.

Clin Cancer Res. 2001 Aug;7(8):2246-53.

PMID:
11489798
[PubMed - indexed for MEDLINE]
Free Article
5.

Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.

Schilsky RL, Bertucci D, Vogelzang NJ, Kindler HL, Ratain MJ.

J Clin Oncol. 2002 Jan 15;20(2):582-7.

PMID:
11786589
[PubMed - indexed for MEDLINE]
6.

Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

Heinemann V, Quietzsch D, Gieseler F, Gonnermann M, Schönekäs H, Rost A, Neuhaus H, Haag C, Clemens M, Heinrich B, Vehling-Kaiser U, Fuchs M, Fleckenstein D, Gesierich W, Uthgenannt D, Einsele H, Holstege A, Hinke A, Schalhorn A, Wilkowski R.

J Clin Oncol. 2006 Aug 20;24(24):3946-52.

PMID:
16921047
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.

Dragovich T, Huberman M, Von Hoff DD, Rowinsky EK, Nadler P, Wood D, Hamilton M, Hage G, Wolf J, Patnaik A.

Cancer Chemother Pharmacol. 2007 Jul;60(2):295-303. Epub 2006 Dec 6.

PMID:
17149608
[PubMed - indexed for MEDLINE]
9.

Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.

Hidalgo M, Castellano D, Paz-Ares L, Gravalos C, Diaz-Puente M, Hitt R, Alonso S, Cortes-Funes H.

J Clin Oncol. 1999 Feb;17(2):585-92.

PMID:
10080603
[PubMed - indexed for MEDLINE]
10.

Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer.

Sudo K, Yamaguchi T, Nakamura K, Denda T, Hara T, Ishihara T, Yokosuka O.

Cancer Chemother Pharmacol. 2011 Feb;67(2):249-54. doi: 10.1007/s00280-010-1311-3. Epub 2010 Mar 30.

PMID:
20352216
[PubMed - indexed for MEDLINE]
11.

Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.

Brade A, Brierley J, Oza A, Gallinger S, Cummings B, Maclean M, Pond GR, Hedley D, Wong S, Townsley C, Brezden-Masley C, Moore M.

Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1027-36. Epub 2006 Dec 29.

PMID:
17197132
[PubMed - indexed for MEDLINE]
12.

A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.

Budiharto T, Haustermans K, Van Cutsem E, Van Steenbergen W, Topal B, Aerts R, Ectors N, Bielen D, Vanbeckevoort D, Goethals L, Verslype C.

Radiat Oncol. 2008 Sep 22;3:30. doi: 10.1186/1748-717X-3-30.

PMID:
18808686
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer.

Ueno H, Okusaka T, Furuse J, Yamao K, Funakoshi A, Boku N, Ohkawa S, Yokosuka O, Tanaka K, Moriyasu F, Nakamori S, Sato T.

Jpn J Clin Oncol. 2011 Aug;41(8):953-8. doi: 10.1093/jjco/hyr090. Epub 2011 Jun 29.

PMID:
21715364
[PubMed - indexed for MEDLINE]
Free Article
14.

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.

Van Cutsem E, van de Velde H, Karasek P, Oettle H, Vervenne WL, Szawlowski A, Schoffski P, Post S, Verslype C, Neumann H, Safran H, Humblet Y, Perez Ruixo J, Ma Y, Von Hoff D.

J Clin Oncol. 2004 Apr 15;22(8):1430-8.

PMID:
15084616
[PubMed - indexed for MEDLINE]
Free Article
15.

A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer.

Ko AH, Truong TG, Kantoff E, Jones KA, Dito E, Ong A, Tempero MA.

Cancer Chemother Pharmacol. 2012 Dec;70(6):875-81. doi: 10.1007/s00280-012-1979-7. Epub 2012 Sep 28.

PMID:
23053263
[PubMed - indexed for MEDLINE]
16.

Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas.

Späth-Schwalbe E, Genvresse I, Koschuth A, Dietzmann A, Grunewald R, Possinger K.

Anticancer Drugs. 2000 Jun;11(5):325-9.

PMID:
10912948
[PubMed - indexed for MEDLINE]
17.

A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer.

Okusaka T, Ishii H, Funakoshi A, Ueno H, Furuse J, Sumii T.

Jpn J Clin Oncol. 2006 Sep;36(9):557-63. Epub 2006 Jul 26.

PMID:
16870696
[PubMed - indexed for MEDLINE]
Free Article
18.

A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Cascinu S, Gasparini G, Catalano V, Silva RR, Pancera G, Morabito A, Giordani P, Gattuso D, Catalano G.

Ann Oncol. 1999 Nov;10(11):1377-9.

PMID:
10631469
[PubMed - indexed for MEDLINE]
Free Article
19.

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.

Boeck S, Hoehler T, Seipelt G, Mahlberg R, Wein A, Hochhaus A, Boeck HP, Schmid B, Kettner E, Stauch M, Lordick F, Ko Y, Geissler M, Schoppmeyer K, Kojouharoff G, Golf A, Neugebauer S, Heinemann V.

Ann Oncol. 2008 Feb;19(2):340-7. Epub 2007 Oct 24.

PMID:
17962204
[PubMed - indexed for MEDLINE]
Free Article
20.

Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.

Niho S, Kubota K, Goto K, Ohmatsu H, Matsumoto T, Kakinuma R, Nishiwaki Y.

Cancer Chemother Pharmacol. 2003 Jul;52(1):19-24. Epub 2003 Apr 24.

PMID:
12712259
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk